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Abstract
The thyroid hormone receptor 1 (TR1) is a nuclear receptor for thyroid hormone that shuttles rapidly
between the nucleus and cytoplasm. Our prior studies showed that nuclear import of TR1 is directed by
two nuclear localization signals, one in the N-terminal A/B domain and the other in the hinge domain.
Here, we showed using in vitro nuclear import assays that TR1 nuclear localization is temperature and
energy-dependent and can be reconstituted by the addition of cytosol. In HeLa cells expressing green
fluorescent protein (GFP)-tagged TR1, knockdown of importin 7, importin 1 and importin 1 by RNA
interference, or treatment with an importin 1-specific inhibitor, significantly reduced nuclear localization
of TR1, while knockdown of other importins had no effect. Coimmunoprecipitation assays confirmed
that TR1 interacts with importin 7, as well as importin 1 and the adapter importin 1, suggesting that
TR1 trafficking into the nucleus is mediated by two distinct pathways.
Key words: thyroid hormone receptor, thyroid hormone, nuclear import, importin
1. Introduction
The thyroid hormone receptor 1 (TR1)1 is a transcription factor in the nuclear receptor superfamily
that either activates or represses transcription of thyroid hormone-responsive genes, depending on its
liganded state. TR1 carries out its function through binding target genes in the nucleus; however, our
previous research has shown that TR1 shuttles back and forth between the nucleus and the cytoplasm
(Bunn et al., 2001; Grespin et al., 2008). An important aspect of nucleocytoplasmic shuttling, and for the
role of TR1 as a transcription factor, is the process by which TR1 is imported into the nucleus from the
cytoplasm by crossing the nuclear envelope. The nuclear envelope creates an intracellular compartment
that enables spatial regulation of gene expression and plays a key role in signal transduction pathways, in
gene activation or repression, and in the regulation of major cellular processes (Lange et al., 2010;
Sekimoto and Yoneda, 2012; Stewart, 2007; Tran et al., 2014).
Nuclear proteins cross the nuclear envelope via large protein assemblages approximately 100 MDa in
size called nuclear pore complexes (NPCs) (Adams and Wente, 2013). Nuclear import of small
The abbreviations used are: TR1, thyroid hormone receptor 1; TR1, thyroid hormone receptor 1;
NPCs, nuclear pore complexes; NLS, nuclear localization signal; RNAi, RNA interference; GFP, green
fluorescent protein; GST, glutathione-S-transferase; shRNA, short hairpin RNA; RT-qPCR, real-time
quantitative PCR; FITC, fluorescein isothiocyanate; RRL, rabbit reticulocyte lysate; TRE, thyroid
hormone response element; T3, 3,3′,5-triiodo-L-thyronine (thyroid hormone).
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molecules, including small proteins (less than 40 kDa), can occur by passive diffusion through the central
channel of the NPCs; however, in most cases, both small and large proteins enter the nucleus by an
energy-dependent, signal-mediated pathway (Gorlich and Kutay, 1999; Gorlich and Mattaj, 1996;
Grossman et al., 2012; Stewart, 2007; Tetenbaum-Novatt and Rout, 2010). Signal-mediated transport
requires soluble factors collectively called karyopherins, or importins, to facilitate translocation into the
nucleus (Pemberton and Paschal, 2005; Sekimoto and Yoneda, 2012; Stewart, 2007), and also relies on an
asymmetrical cellular distribution of the small GTPase Ran in either its GTP or GDP bound state. A high
nuclear RanGTP concentration is required for dissociation of import complexes that have successfully
passed through the NPC (Fried and Kutay, 2003; Gorlich et al., 1997; Gorlich et al., 1996; TetenbaumNovatt and Rout, 2010; Wente and Rout, 2010). Adding to the complexity of mechanisms for nuclear
entry, a recent report suggests that an importin-dependent nuclear import pathway can be accessed by
proteins with conserved ankyrin repeats (Lu et al., 2014). Importins bind to a cargo protein by
recognizing a short lysine or arginine-rich amino acid motif on the cargo protein known as a nuclear
localization signal (NLS). Two NLSs in TR1 have been fully characterized: NLS-1, a classical bipartite
NLS in the hinge region (Baumann et al., 2001; Casas et al., 2006; Lee and Mahdavi, 1993; Maruvada et
al., 2003; Mavinakere et al., 2012; Zhu et al., 1998) and, more recently, NLS-2, a novel, monopartite NLS
in the N-terminal A/B domain (Mavinakere et al., 2012).
The karyopherin- family is responsible for the majority of nuclear transport pathways, with each
member performing a distinct nuclear import, export, or bi-directional transport function (Cook et al.,
2007; Macara, 2001; Strom and Weis, 2001; Xu et al., 2010). Members of this family involved in nuclear
import are characterized by their ability to either bind NLS-bearing cargo directly or indirectly via an
adaptor importin (Cingolani et al., 2002; Lott and Cingolani, 2011; Palmeri and Malim, 1999). Importin
1 is the best-studied member of the karyopherin-1 family, which includes 10 other known family
members that can mediate import of proteins into the nucleus (Lange et al., 2007; Mosammaparast and
Pemberton, 2004; Pemberton and Paschal, 2005; Stewart, 2007; Strom and Weis, 2001). Most nuclear
import occurs via direct binding of a karyopherin- receptor to a cargo protein. In the classical nuclear
import model, however, importin  acts as an adaptor protein that recognizes and binds to a specific NLS
motif on the cargo, and then binds importin 1 (Lange et al., 2007; Riddick and Macara, 2005, 2007). The
human genome encodes at least six importin α isoforms: 1, 3, 4, 5, 6, and 7 (Friedrich et al.,
2006). Each importin  isoform is responsible for binding to and facilitating import of several different
cargo proteins in conjunction with importin 1 (Cook et al., 2007; Goldfarb et al., 2004; Lange et al.,
2010; Lange et al., 2007).
In the present study, we sought to characterize the general mechanism for TR1 transport, using in
vitro nuclear import assays. Additionally, we used RNA interference (RNAi), treatment with importazole,
an importin 1-specific inhibitor, and coimmunoprecipitation assays in HeLa cells to identify which
importins mediate nuclear import of TR1. Taken together, our in vitro and in vivo data suggest that
TR1 can follow two distinct temperature and energy-dependent, signal-mediated import pathways, with
importin 7, importin 1, and the adapter importin 1 acting as major players in localizing TR1 to the
nucleus.
2. Methods
2.1. Plasmids and recombinant proteins
pGFP-TR1 is an expression plasmid for functional green fluorescent protein (GFP)-tagged rat TR1
(Bunn et al., 2001), and the expression vector for enhanced GFP, EGFP-C1, was obtained from Clontech
Laboratories, Inc. (Mountain View, CA). The plasmid GFP-TR1 encodes GFP-tagged human TR1
(Mavinakere et al., 2012). The GFP-glutathione-S-transferase (GST)-GFP (G3) expression vector, G3A/BD (containing NLS-2) expression plasmid, and G3-Hinge (containing NLS-1) expression plasmid
were previously described (Mavinakere et al., 2012). The plasmid hTERT-GFP was a gift from R. H.
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Kehlenbach (University of Göttingen) and encodes GFP-tagged human telomerase reverse transcriptase
(Frohnert et al., 2014). pGST-GFP-NLS was a gift from R. J.G. Haché (University of Ottawa) and
expresses a fusion protein comprised of GST and GFP with the sequence of the simian virus 40 (SV40)
T-antigen NLS (PKKKRKV) at the C terminus (Walther et al., 2003). pGEX-2T-T3R was a gift from
M. Privalsky (University of California) and encodes GST-tagged TR1 (Tzagarakis-Foster and Privalsky,
1998). Pre-designed SureSilencing™ short hairpin RNA (shRNA) plasmid sets, consisting of four
different shRNA expression plasmids for each target mRNA, were purchased from SABioscience
(Frederick, MD) for human importin 1 (KPNA2), importin 3 (KPNA4), importin 4 (KPNA3),
importin 5 (KPNA1), importin 7 (KPNA6), importin 1 (KPNB1), importin 4 (IPO4), importin 5
(IPO5), importin 7 (IPO7), importin 8 (IPO8), importin 9 (IPO9), importin 11 (IPO11), importin 13
(IPO13), and a scrambled sequence negative control. The sequences of all shRNAs are provided as
supplementary information (Table S1). 2xDR4-SV40-Luc was a gift from J. L. Jameson (Northwestern
University), and consists of two copies of a positive, direct repeat TRE (DR+4) in the firefly luciferase
vector pGL3. The plasmid pGL4.74 encodes Renilla luciferase (Promega, Madison, WI).
2.2. Protein purification and FITC labeling
Recombinant GST-tagged TR1 was bacterially expressed and purified by binding and elution from
Glutathione-Sepharose 4B resin (GE Healthcare Life Sciences, Pittsburgh, PA), as described (Grespin et
al., 2008). Protein samples were analyzed by 8% or 12% SDS-PAGE and protein concentration was
estimated using a NanoDrop® ND-1000 full-spectrum UV/Vis Spectrophotometer. Samples were stored
at 80oC. For import assays, purified GST-TR1 was labeled with fluorescein isothiocyanate (FITC)
using a FluoReporter® Protein Labeling Kit (Life Technologies, Grand Island, NY), according to the
manufacturer’s instructions. The labeled sample was dialyzed against PBS overnight at 4oC, and
concentrated using Micron Ultracel YM-30 Centrifugal Filter Devices (Millipore, Bedford, MA). Samples
were stored at 80oC.
2.3 Permeabilized cell nuclear import assays
HeLa cells (American Type Culture Collection [ATCC], #CCL-2) were cultured in Minimum
Essential Medium (MEM) supplemented with 10% fetal bovine serum (FBS) (Life Technologies) at 37ºC
under 5% CO2 and 98% humidity. HeLa cells were seeded on 22 mm Coverslips for Cell Growth™
(Fisher Scientific, Pittsburgh, PA) in 6 well culture dishes at a density of 2-3 x 105 cells per well. Sixteen
to 24 h hours post-seeding the medium in each well was replaced with fresh MEM supplemented with
10% FBS. After 4 h, cells were washed 2X with 2 ml per well cold Import Buffer (20 mM HEPES, pH
7.3, 110 mM KOAc, 5 mM NaOAc, 2 mM Mg[OAc]2), then permeabilized with 50 g/ml digitonin
(Calbiochem, San Diego, CA) in Import Buffer for 4 min at room temperature. Cells were rinsed 1X with
2 ml per well cold Import Buffer for 10 min, and coverslips were then inverted over 50 l drops of Import
Reaction Mix (energy regeneration system composed of 5 mM creatine phosphate, 20 U/ml creatine
phosphokinase, 0.5 mM ATP, and 0.5 mM GTP in Import Buffer; 0.67 mM FITC-labeled GST-TR1;
and 25 l rabbit reticulocyte lysate or Import Buffer) on parafilm in a moist chamber for 30 min at 30oC.
For energy depletion, the energy regeneration system was replaced with apyrase (Grade VIII, 100 U/ml,
Sigma-Aldrich, St. Louis, MO). Subsequently, cells were fixed in 3.7% formaldehyde (Fisher Scientific)
for 10 min, followed by a 5 min wash with Import Buffer. Coverslips were mounted on slides with
Fluoro-Gel II mounting medium (Electron Microscopy Sciences, Hatfield, PA) containing the DNA
counter stain 4′,6-diamidino-2′-phenylindole dihydrochloride (DAPI, 0.5 g/ml). Cells were analyzed for
nuclear localization of FITC-GST-TR1 by fluorescence microscopy.
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2.4 Importazole treatment
HeLa cells were seeded on coverslips in 6 well culture dishes at a density of 2.0-2.5 x 105 cells per
well. Twenty four hours post-seeding, cells were transfected with 2 g of GFP-TR1 or GFP-TR1
expression plasmid using Lipofectamine 2000 (Life Technologies). The transfection medium was
replaced with fresh MEM containing 10% FBS at 5 h post-transfection. Approximately 18 h later, cells
were treated for 5 h with 50 M importazole (Calbiochem) or an equivalent volume of ethanol (vehicle
control). Cells were fixed in 3.7% formaldehyde, and coverslips were mounted with Fluoro-Gel II
containing DAPI (0.5 g/ml), and then analyzed for the cellular localization of GFP-TR1 or GFP-TR1
by fluorescence microscopy.
2.5 Analysis of nuclear localization by RNA interference (RNAi)
HeLa cells were seeded on coverslips in 6 well culture dishes at a density of 2.0-2.5 x 105 cells per
well. Twenty four hours post-seeding, cells were cotransfected with 1 g of the appropriate set of four
target-specific or control shRNA expression plasmids and 1 g GFP-TR1 expression plasmid using
Lipofectamine 2000. The transfection medium was replaced with fresh MEM containing 10% FBS at 8 h
post-transfection. At exactly 26 h post-transfection, cells were fixed and analyzed for the cellular
localization of GFP-TR1 by fluorescence microscopy. In pilot studies, a range of post-transfection
incubation times (17 h, 24 h, 26 h, and 30 h) were tested. In addition, we varied the amount of
Lipofectamine 2000 and the time cells were exposed to the reagent, selected for knockdown cells with
puromycin, and varied the shRNA plasmid amounts and combinations. The conditions described above
showed high transfection efficiency (50-70% of cells were transfected), reduced the levels of importins in
cells, and retained cell viability. Altered conditions either decreased transfection efficiency, decreased
knockdown efficiency, or led to increased cell mortality. Cell mortality was assessed by visual inspection
of the number of adherent cells before and after transfection, with the standard set at >60% retention.
2.6 Validation of RNAi by real-time quantitative PCR (RT-qPCR)
HeLa cells were seeded on 100 mm vented plates at a concentration of 6 x 105 cells per plate in MEM
supplemented with 10% FBS. Twenty four hours post-seeding, each plate was transfected with 10 µg of a
set of four target-specific or control shRNA expression plasmids using Lipofectamine 2000. The
transfection medium was replaced with fresh MEM containing 10% FBS at 8 h post-transfection. At
exactly 26 h post-transfection, total RNA was purified using the AurumTM Total RNA Mini Kit (Bio-Rad,
Hercules, CA), following the Spin Protocol for Cultured Mammalian Cells with a 30 min DNase I
digestion. Only RNA samples with A260:A280 ratios greater than 2.0 and A260:A230 ratios greater than
1.7 were used. RNA quality and integrity was further analyzed using an RNA 6000 Pico Total RNA
Assay and the Agilent 2100 BioAnalyzer’s Lab-on-a-Chip technology (Santa Clara, CA).
cDNA was synthesized using SABioscience RT2 First Strand Kit and 0.74 g total RNA. This amount
of total RNA was within the manufacturer’s recommended range, and was selected to standardize all
cDNA synthesis reactions. Samples for real-time quantitative PCR (RT-qPCR) were set up in a 48-well
plate, using RT2 SYBR Green/Fluorescein qPCR Master Mix (SABioscience) and SABioscience
validated RT2-qPCR primers specific for importins 7, 1, 1, 3, 4, 5, 7, or glyceraldehyde-3phosphate dehydrogenase (GAPDH) as an internal control. No Template controls and No Reverse
Transcription controls also were included for each sample. Plates were centrifuged for 90 sec at 500 x g in
a Peqlab PerfectSpin plate spinner (VWR International, Radnor, PA), then analyzed using an Applied
Biosystems StepOneTM Real-Time PCR machine (Life Technologies) as follows: 10 min at 95°C, then 40
cycles of 15 sec at 95°C, 35 sec at 55°C, and 30 sec at 72°C. SYBR Green fluorescence was detected and
recorded during the annealing step of each cycle. A melting curve analysis was performed as a quality
control measure. RT-qPCR data were analyzed by the ΔΔCt (Livak) method (Livak and Schmittgen,
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2001) using StepOneTM software, and validated by manual calculation.
2.7 Validation of RNAi by immunoblotting
Twenty six hours post-transfection, HeLa cell protein lysates were prepared and analyzed by
immunoblotting as described (Subramanian et al., 2015). Antibodies were used with the following
concentrations: anti-GAPDH (Santa Cruz Biotechnology Inc, Dallas, TX), 1:5000; anti-importin 1
(Santa Cruz), 1:2000; anti-importin 4 (Santa Cruz), 1:333; anti-importin 5 (Santa Cruz), 1:10,000; antiimportin 7 (Abcam, Cambridge, MA), 1:1000; anti-importin 8 (Abcam), 1:250; anti-importin 9 (Abcam),
1:250; anti-importin 11 (Abcam), 1:333; anti-importin 13 (Santa Cruz), 1:100; anti-importin 1 (Santa
Cruz), 1:2000; anti-importin 3 (Thermo Scientific), 0.2 g/ml; horseradish peroxidase (HRP)conjugated donkey anti-rabbit IgG (GE Healthcare Life Sciences), 1:25,000; HRP-sheep anti-mouse IgG
(GE Healthcare Life Sciences), 1:25,000; or HRP-mouse anti-goat IgG (Santa Cruz Biotechnology),
1:25,000. Protein size was confirmed using Pre-Stained Kaleidoscope Protein Standards (Bio-Rad,
Hercules, CA). X-ray films were quantified by scanning densitometry using NIH ImageJ software.
2.8 Cell scoring by fluorescence microscopy and statistical analysis
For some analyses an inverted Nikon ECLIPSE TE 2000-E fluorescence microscope (Nikon
Ultraviolet Excitation: UV-2E/C filter block for DAPI visualization; Blue Excitation: B-2E/C filter block
for GFP/ FITC visualization) was used with a Nikon Plan Apo 40x/0.95objective. A CoolSNAP HQ2
CCD camera (Photometrics, Tucson, AZ) and NIS-Elements AR software (Nikon) were used for image
capture. For other analyses an Olympus BX60 microscope (U-MNU filter cube for DAPI; Omega Optical
XF100-2 for GFP) was used with an Olympus 40xUPlanFL 40x/0.75 objective. A Cooke SenisCamQE
camera and IPlab software (BD Biosciences Bioimaging Rockville, MD) were used for image capture.
Images were presented using Adobe Photoshop/Illustrator.
For permeabilized cell in vitro nuclear import assays, the localization of FITC-GST-TR1 was scored
as “nuclear” when there was a detectable accumulation of fluorescence within the nucleus. FITC-GSTTR1 that did not accumulate in the nucleus diffused out into the drop of Import Buffer (see Section 2.3),
since the cells were permeabilized. Import assays consisted of 4 to 5 independent, biological replicates,
with 200 cells scored per replicate. For RNAi experiments, the localization of GFP-TR1 was scored in
one of three categories: completely nuclear, nuclear and cytoplasmic (with distinct accumulation in the
nucleus), or whole cell (with no distinct nuclear accumulation). RNAi experiments consisted of 3
independent, biological replicates, with 100 cells scored per replicate. To ensure consistency in scoring
criteria, slides were randomly selected for cross-checking by other lab members. In all experiments, the
integrity and morphology of the DAPI-stained nuclei was assessed visually, and only cells with intact
nuclei were scored. All cell counts were performed blind, without prior knowledge of the treatment. The
slides’ original labels were removed and replaced with random numbers by another lab member, who
made a key and kept it secure until scoring was completed and data were analyzed. For some RNAi
experiments, one lab member set up the transfection and prepared slides, while another lab member
scored the slides blind. Data were quantified as the percentage of cells in a given category (e.g., % of cells
with a primarily nuclear distribution of TR1) and presented as bar graphs. Bars indicate the mean
percentage of cells in a given category, and error bars indicate plus or minus the standard error of the
mean ( SEM). Statistical differences between two groups were determined using an unpaired Student’s t
test with two-tailed P value. Results were considered significant at P<0.05.
2.9. Luciferase reporter gene assay
Cells were seeded at 2.0 x 104 per well in a 96-well plate (PerkinElmer, Waltham, MA). Seventeen
hours after seeding, cells were transiently transfected with 100 ng DNA, containing 25 ng each of
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expression plasmids for GFP-TRα1, TRE (DR+4)-firefly luciferase reporter, Renilla luciferase internal
control, scrambled shRNA control or a set of four target-specific shRNAs. Transfection medium was
replaced with complete medium 8 h post-transfection. Fourteen hours post-transfection, complete medium
was replaced with 100 l MEM containing 10% charcoal-dextran stripped FBS (Life Technologies),
supplemented or not with 100 nM 3,3′,5-triiodo-L-thyronine (T3, Sigma-Aldrich). After an additional 12
h, a Dual-Glo® Luciferase Assay (Promega) was performed, according to the manufacturer’s protocol,
using 100 l of reagent per well. Four independent, biologically separate replicate experiments were
performed, with 8 wells assayed per treatment. Data were analyzed for statistical significance, as
described in Section 2.8.
2.10 GFP-Trap_A coimmunoprecipitation
HeLa cells were seeded on 100 mm vented plates at a concentration of 9 x 105 cells per plate in MEM
supplemented with 10% FBS. Twenty four hours post-seeding, each plate was transfected with expression
plasmids encoding GFP, GFP-TR1, hTERT-GFP, GST-GFP-NLS, GFP-TR1, GFP-GST-GFP (G3),
G3-A/BD, or G3-Hinge, using Lipofectamine 2000. After 26 h, cells were washed with ice-cold
Dulbecco’s phosphate-buffered saline (PBS), treated for 3 min with 0.7 ml of 0.25% trypsin (Life
Technologies), collected in 1.0 ml MEM supplemented with 10% FBS, then transferred to 2.0 ml
microcentrifuge tubes. Cells were washed 2X with Dulbecco’s PBS, then lysed in 200 µl of Lysis Buffer
(10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 0.5 mM EDTA) containing 0.5% IGEPAL (NP-40
equivalent, Sigma-Aldrich) and 1X Halt Protease Inhibitor Cocktail (Thermo Scientific). Cells were
incubated for 30 min on ice, with thorough pipetting every 10 min. The lysate was cleared by
centrifugation at 4°C, 16,000 x g for 10 min, and the supernatant was transferred to a new tube and
diluted with 300 µl of Dilution/Washing Buffer (2 mM Tris-HCl, pH 7.5, 30 mM NaCl, 0.1 mM EDTA),
containing 1X Halt Protease Inhibitor Cocktail, to yield a final concentration of 0.2% IGEPAL. GFP-trap
agarose beads (GFP-Trap_A, Chromotek GmbH, Planegg-Martinsried, Germany) were pre-equilibrated
by washing 3X with Dilution/Washing Buffer, then 20 l were added to each diluted supernatant. After
2.5 h of incubation at 4°C with end-over-end rotation, beads were centrifuged at 4°C, 3000 x g for 4 min.
A 50 µl sample of the supernatant (unbound proteins) was collected and resuspended with an equal
volume of 2X Sample Buffer (2% SDS, 10% glycerol, 250 mM Tris-HCl, pH 6.8, 0.01% bromophenol
blue, 20 mM DTT). The beads were washed 3X with 100 µl Dilution/Washing Buffer lacking IGEPAL,
then resuspended in 100 µl of 2X Sample Buffer. Samples of unbound and bound proteins (20 l) were
analyzed by immunoblotting (see Section 2.7), using SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Scientific). Antibodies were used at the following concentrations: anti-GFP (Santa
Cruz), 1:2000; anti-importin 4 (Abcam), 1:1250; anti-importin 7 (Abcam), 1:1000; anti-importin 1
(Santa Cruz), 1:1000; anti-importin 1 (Abcam), 1:1000; horseradish peroxidase (HRP)-conjugated
donkey anti-rabbit IgG (GE Healthcare Life Sciences), 1:25,000 or 1:33,000.
3. Results
3.1. TR1 follows a signal-mediated import pathway in HeLa cells
Our prior studies showed that TR1 follows both signal-mediated and passive diffusion import
pathways in Xenopus oocytes (Bunn et al., 2001). We also showed that there is an energy-requiring step
in the nuclear retention or nuclear export process in mammalian cells; however, we did not address the
import mechanism in mammalian cells. Given the specialized nature of these amphibian oocytes, it was of
interest to determine whether TR1 would follow a signal-mediated import pathway in mammalian cells.
To this end, permeabilized HeLa (human) cell in vitro nuclear import assays (Adam et al., 1990) were
used to address this question.
To test whether soluble factors are required for nuclear entry of TR1, FITC-labeled recombinant
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GST-TR1 was used for import assays in the presence or absence of rabbit reticulocyte lysate (RRL), as a
cytosol replacement. In the presence of RRL, TR1 was able to translocate into the nucleus from its
starting point in the cytoplasm. After 30 min incubation at 30oC, on average 61% of cells showed a
predominantly nuclear localization of TR1. In the absence of RRL, TR1 showed a significantly
different localization pattern (Fig. 1, A and B; P=0.00001); the receptor did not accumulate in the
nucleus, and formed aggregates or showed fluorescent staining of the nuclear periphery, an indicator of
binding at the NPC without subsequent translocation (Newmeyer and Forbes, 1988). On average, TR1
was only localized to the nucleus in 11% of cells .
Next, we sought to determine whether TR1 import was temperature-dependent. Chilling has been
shown to abolish active transport while only marginally affecting passive transport (Breeuwer and
Goldfarb, 1990; Freedman and Yamamoto, 2004). However, given that FITC-GST-TR1 is 73 kDa in
size, this likely would preclude rapid passive diffusion through the NPCs regardless of temperature.
Import reactions were incubated at 4oC for 30 min. Nuclear import of FITC-GST-TR1 was significantly
inhibited in chilled cells (Fig. 1, A and B; P=0.007); on average, only 26% of cells showed nuclear
accumulation of TR1. Nuclear import could be fully restored, however, by further incubation at 30oC
(P=0.584). Reversible inhibition suggests that chilling blocked TR1 import by inhibiting specific
transport components, rather than by preventing import by way of non-specific cellular damage (Bunn et
al., 2001).
To further characterize the energy requirements for nuclear import of TR1 in permeabilized HeLa
cells, the effects of energy depletion were studied by apyrase treatment, which depletes cellular ATP and
GTP (Bunn et al., 2001). Import assays were performed in the presence of RRL, as a cytosol replacement,
and in the presence of an energy regeneration system or apyrase (Fig. 1, A and B). Incubation at 30oC for
30 min with apyrase significantly inhibited nuclear accumulation of FITC-GST-TR1 (P=0.025). On
average, only 40% of cells showed nuclear localization of TR1, compared to reactions containing RRL
and an energy regeneration system in which TR1 was localized primarily to the nucleus in 61% of cells.
However, TR1 import in the presence of apyrase was not inhibited to the same extent as import in the
absence of RRL, where only 11% of cells showed nuclear accumulation of TR1.
Soluble factor dependence, chilling inhibition, and energy dependence are commonly used criteria
when establishing a signal-mediated import pathway (Carazo et al., 2012; Dhanoya et al., 2013; Umemoto
and Fujiki, 2012; Vazquez-Iglesias et al., 2009, 2012), and thus demonstrate a requirement for signalmediated nuclear import of TR1 in HeLa cells. To begin to characterize the soluble components
required for nuclear localization of TR1, we turned to an in vivo approach to evaluate the role of a panel
of importins in promoting TR1 nuclear import in HeLa cells.
3.2 Knockdown of importin 1 and importin 7 reduces TR1 nuclear localization
RNAi is a powerful tool for knockdown of the expression of a specific gene in vivo by targeting its
mRNA for degradation. We chose to use importin-specific shRNA expression plasmids, to ensure
sustained depletion of protein levels. Since TR1 is primarily nuclear at steady-state, but shuttles between
the nucleus and the cytosol, effective knockdown of an essential import factor would be predicted to
result in a shift to a more cytoplasmic distribution of TR1 over time. It is important to note, however,
that it was not expected that cells would ever show a fully cytoplasmic distribution of TR1 for a number
of reasons. First, RNAi leaves a residual portion of target mRNA and protein in cells. Second, a wholly
cytoplasmic distribution would depend on the complete export of all nuclear TR1, which is unlikely as it
is strongly retained in the nucleus by interaction with target genes.
Although the classical importin 1/1 import pathway is widely used by nuclear proteins, and was
thus a priority to investigate, other import pathways exist. Of particular interest for this study, importin 7
mediates nuclear import of a diversity of cargos including the glucocorticoid receptor (Chook and Suel,
2011; Strom and Weis, 2001). Thus, we also evaluated importin 7 for its role in promoting TR1 nuclear
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localization. First, shRNA-induced knockdown of importin 1 and importin 7 mRNA was validated by
RT-qPCR and protein levels were quantified by immunoblot analysis. Twenty six hours post-transfection
with shRNA expression plasmids, the levels of importin 1 and importin 7 mRNA in HeLa cells were
reduced to 21% and 19%, respectively, relative to the control shRNA (set to 100%) (Fig. 2A). Importin
1 and importin 7 protein levels were reduced to 56% and 49%, respectively, relative to the scrambled
control (Fig. 2B), indicating the efficacy of the RNAi system. Control immunoblots also confirmed the
specificity of shRNA-mediated knockdown of importin 7, importin 1, and importin 1 (see Section 3.3);
shRNA-targeting a particular importin did not exhibit any cross-inhibition of another importin (Fig. 2C).
Next, in a parallel experiment, the effect of importin 1 and importin 7 knockdown on the cellular
localization of GFP-TR1 at 26 h post-transfection was assessed by fluorescence microscopy.
Knockdown of importin 1 resulted in a significant shift in localization of TR1 to a more cytoplasmic
distribution (P=0.002); on average only 72% of cells showed TR1 primarily localized to the nucleus,
compared with 86% of cells in the presence of control shRNA (Fig. 3, A and B).
Knockdown of importin 7 caused a significant shift in localization of TR1 to a more cytoplasmic
distribution (Fig. 3, A and B; P=0.0001); on average, only 66% of cells showed TR1 localized to the
nucleus, with a concomitant increase in the number of cells with a whole cell distribution of TR1. In
addition, many of these cells were marked by numerous small cytoplasmic or perinuclear aggregates of
TR1. Such an accumulation of foci was typically not observed upon knockdown of the other importins
tested. Interestingly, knockdown of importin 7 has been shown to alter nucleolar morphology, resulting in
a more punctate distribution of fibrillarin (Golomb et al., 2012). Taken together our findings suggest that
both importin 1 and importin 7 play key roles in promoting nuclear localization of TR1 in vivo.
3.3. Knockdown of importin 1 reduces TR1 nuclear localization
In an effort to further characterize additional importins playing a role in the signal-mediated import
pathway, the adaptor importins 1, 3, 4, 5, and 7 were screened as well. Importin 6 was excluded
from the analysis because its expression appears to be limited to the testis (Chook and Suel, 2011). These
importins are known to mediate import in conjunction with importin β1 in the classical nuclear import
pathway. We were unable to achieve sufficient knockdown of the levels of importin 5 mRNA; levels
only were reduced to 68% relative to the control shRNA with the set of four shRNA expression plasmids
used. Thus, further analysis of this adaptor protein was not performed. In contrast, levels of importin 1
mRNA were knocked down to 23% of control levels, while levels of importin 3, 4, and 7 mRNA
were knocked down to 5%, 16%, and 8%, respectively (Fig. 4A). Accordingly, levels of importin 1, 3,
and 7 proteins were knocked down to 55%, 49%, and 49%, respectively, compared with the scrambled
control (Fig. 4B). At the time this study was performed, no antibodies were available for importin 4, so
we were only able to assess knockdown via RT-qPCR in this case.
Knockdown of importin 1 resulted in a significant shift of TR1 towards a more cytoplasmic
distribution (Fig. 4, C and D; P=0.025); on average, only 71% of cells showed a primarily nuclear
localization of TR1, compared to 86% of cells in the shRNA control (Fig. 4, C and D). There was no
significant change in nuclear localization in cells depleted of importin 3 (P=0.190), importin 4
(P=0.425) and importin 7 (P=0.721) (Fig. 4D), although results with importin 7 were highly variable
between replicates. These findings suggest that importin 1 is the main adaptor acting with importin 1
for nuclear localization of TR1.
We thought that dual knockdown with combinations of shRNA against importin 1/importin 1 or
importin 7/importin 1 might have a greater impact than single knockdowns. However, these
combinations did not result in further shifts in the distribution pattern of TR1, although this could well
be due to increased cell mortality. These importins are required for nuclear localization of many other
proteins involved in essential cell processes. In addition, since cellular microRNAs (miRNAs) regulate
the expression of hundreds of genes, saturation of the RNAi pathway with exogenous shRNA also could
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contribute to loss of cell viability (Castanotto and Rossi, 2009; Scherr and Eder, 2007). Further, it is likely
that the primarily nuclear location of TR1 at steady-state limits how much the distribution pattern can be
altered over the time course of an experiment. We found that extending the time course for knockdown of
importins beyond 26 h post-transfection caused a marked decrease in cell viability, in particular for
importin 1. This is consistent with a report that reduced levels of importin 1 are more harmful to a cell
than reduction in the levels of importin  (Quensel et al., 2004).
3.4. Nuclear import of TR1 and TR1 is inhibited by importazole
To provide further evidence that importin β1 plays a role in mediating TR1 nuclear localization, we
made use of importazole, a small molecule inhibitor of this pathway. Importazole specifically blocks
importin β1-mediated nuclear import, without disrupting transportin-mediated nuclear import or CRM1mediated nuclear export (Soderholm et al., 2011). Treatment of GFP-TR1-expressing HeLa cells with
importazole resulted in a 16% reduction in nuclear localization of TR1 compared with cells treated with
the vehicle control (P=0.000001) (Fig. 5A), providing further support for a central role of importin 1 in
TR1 nuclear localization.
The nuclear localization signal, NLS-1, in the hinge domain of TR1 is conserved in the other major
TR subtype, the thyroid hormone receptor 1 (TR1); however, NLS-2 in the A/B domain of TR1 is
absent from TR1 (Mavinakere et al., 2012). TR1 typically has a small cytosolic population at steadystate, suggesting that its distinct distribution pattern may reflect an altered balance of nuclear import and
nuclear export activity, relative to TR1. We thus included TR1 in our analysis to provide a means of
teasing apart whether importin 7 and the importin 1/1 heterodimer interact selectively with one or the
other NLS. Treatment of GFP-TR1-expressing HeLa cells with importazole resulted in a 12% reduction
in nuclear localization of TR1 compared with cells treated with the vehicle control (P=0.001) (Fig. 5B),
suggesting that importin 1 plays a role in TR1 nuclear localization, and that the interaction is mediated
by the hinge domain NLS-1.
3.5. Analysis of other import pathways
Having shown that TR1 localization is influenced by knockdown of importin 7, importin 1, and
importin 1, the question still remained of whether additional pathways for nuclear entry are followed by
TR1. To determine whether other importins play a role in TR1 nuclear localization, we screened the
remainder of the well-characterized importins (Chook and Suel, 2011; Kimura and Imamoto, 2014).
Given the structural similarity between importin 4 and importin 1 (Pradeepa et al., 2008), and that
importin 4 mediates import of another member of the nuclear receptor superfamily, the vitamin D
receptor (Miyauchi et al., 2005), we predicted that importin 4 might also influence TR1 accumulation.
Many cargoes that are primarily imported by importin 4 also use importin 5 as an alternative pathway
(Chook and Suel, 2011). Thus, we predicted that if importin 4 was a mediator of TR1 import, then
knockdown of importin 5 would have no effect on TR1 nuclear localization when importin 4 was
present in the cell. Importin 8 is structurally similar to importin 7 (Chook and Suel, 2011; Weinmann et
al., 2009), so it was also conceivable that this importin could play a role in TR1 import. In addition,
importin 13 has been shown to be one of the importins that mediates glucocorticoid receptor import (Tao
et al., 2006), so importin 13 also appeared to be a likely candidate. Importin 9 imports some ribosomal
proteins (Jakel et al., 2002) and nuclear actin (Kimura and Imamoto, 2014), while importin 11 imports the
ubiquitin-conjugating enzyme, UbcM2 (Plafker and Macara, 2000). No role has yet been reported for
these karyopherins, or for transportins 1 and 2 (Twyffels et al., 2014), in import of nuclear receptors, so
they were considered less likely candidates. In a separate study focused on TR1 nuclear export
pathways, we confirmed that transportins 1 and 2 are not involved in nuclear import (or export) of TR1
(Subramanian et al., 2015).
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Efficacy of knockdown was assessed by immunoblotting (Fig. 6A), with levels of knockdown relative
to the scrambled control as follows: importin 4, 61%; importin 5, 63%; importin 8, 65%; importin 9, 51%,
importin 11, 55%, and importin 13, 59%. There was no significant change in nuclear localization of
TR1 in cells depleted of importin 4 (P=0.99), importin 5 (P=0.34), importin 8 (P=0.60), importin 9
(P=0.89), importin 11 (P=0.55), and 13 (P=0.70), relative to the scrambled control (Fig. 6, B and C).
Taken together, these data indicate that importins 4, 5, 8, 9, 11, and 13 either play no role in localizing TR
to the nucleus, or are minor, nonessential mediators of nuclear localization, relative to importin 7 and the
importin 1/1 heterodimer.
Given that TR1 is a transcription factor that either represses or stimulates expression of T3responsive genes, we sought to ascertain whether the cytoplasmic shift in TR1’s distribution resulting
from knockdown of importins 7, 1, or 1 would reduce TR1-mediated gene expression to a
comparable extent. A firefly luciferase reporter gene under the positive control of a thyroid hormone
response element (TRE) was used to examine ligand-dependent transactivation by GFP-TR1 (Fig. 7), in
the presence of shRNAs specific for importin 4 (no cytoplasmic shift), importin 1, importin 7, or
importin 1. Fold stimulation in the presence of importin-specific shRNAs was not significantly different
compared with fold stimulation in the presence of the scrambled shRNA control (importin 4, P=0.62;
importin 1, P=0.09; importin 7; P=0.24; importin 1, P=0.27), indicating that under these conditions a
reduction in nuclear TR1 of 14-20% does not have a measurable impact on reporter gene expression. As
noted earlier, these importins are required for nuclear localization of many other proteins involved in
transcriptional regulation. Importin knockdown is not specific for TR1 import and, thus, may impact
transcriptional output in complex, unanticipated ways.
3.6. Importin 7, importin 1, and importin 1 interact with TR1
Since knockdown of importin 7, importin 1, and importin 1 leads to a significant shift in TR1
localization to a more cytoplasmic distribution, we sought to ascertain whether this shift correlates with
protein-protein interactions. To confirm that these importins interact with TR1 in vivo, we performed
“GFP-trap” coimmunoprecipitation assays on lysates from HeLa cells that had been transfected with
expression plasmids for GFP, GFP-TR1, GFP-TR1, or GST-GFP-NLS, a fusion protein containing
the classical SV40 NLS (Lange et al., 2010; Walther et al., 2003) (Fig. 8). We confirmed that GFP, GFPTR1, GFP-TR1, and GST-GFP-NLS were all successfully immunoprecipitated by the GFP-trap assay,
by immunoblot analysis of immunoprecipitate samples with anti-GFP antibodies (Fig. 8A). Samples of
unbound proteins (immunosupernatant) and bound proteins (immunoprecipitates) were also analyzed for
the presence of different importins on separate blots using importin-specific antibodies (Fig. 8B).
Endogenous importin 1, importin 1, and importin 7 were coimmunoprecipitated (trapped) with GFPTR1, but not with GFP, indicating that these transport factors specifically interact with TR1 in vivo,
either as part of a complex (e.g., importin 1 via the adaptor importin 1) or separately. In contrast, GSTGFP-NLS trapped importin 1 and importin 1, but did not interact with importin 7 (Fig. 6B). As a
positive control for the method we also confirmed that importin 7 coimmunoprecipitated with hTERTGFP (data not shown), as this interaction had been reported previously (Frohnert et al., 2014). Finally,
we used importin 4 as a negative control, since knockdown of cellular levels of importin 4 had no effect
on TR1 localization. As expected, importin 4 was not trapped by GFP, GFP-TR1, or GST-GFP-NLS
(Fig. 8B), further validating the RNAi screen as a predictive tool for assessing the role of different
importins in mediating nuclear import.
To examine whether importin 7 and the importin 1/1 heterodimer interact selectively with NLS-1
(hinge domain) or NLS-2 (A/B domain) in TR1, we used two different approaches. First, we
investigated whether TR1, which only contains NLS-1, interacts with these importins, using the GFPtrap assay. Samples of unbound proteins (immunosupernatant) from GFP-TR1-expressing HeLa cell
lysates and bound proteins (immunoprecipitates) were analyzed for the presence of “trapped” importins
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by immunoblotting using importin-specific antibodies (Fig. 8C). Endogenous importin 1 and the adaptor
importin 1 were coimmunoprecipitated with GFP-TR1, but not with GFP (in some assays there was a
trace amount of non-specific trapping of importins by GFP), indicating that these transport factors
specifically interact with TR1 in vivo. In contrast, importin 7 did not show interaction above background
levels with GFP-TR1 (Fig. 8C).
In a second approach, we investigated whether the TR1 hinge domain or the A/B domain alone,
fused with GFP-GST-GFP (G3) interacted with these importins. We have previously shown that G3Hinge has a predominantly nuclear localization, comparable to full-length TR1, whereas only around
50% of cells show a predominantly nuclear localization of G3-A/BD (Mavinakere et al., 2012), indicating
that NLS-2 is less efficient in facilitating nuclear import in isolation. HeLa cells were transfected with
expression plasmids for G3, G3-Hinge, or G3-A/BD and immunoprecipitated by the GFP-trap assay.
Samples of unbound proteins and bound proteins were analyzed for the presence of G3 fusion proteins
with GFP-specific antibodies (data not shown), and with the different importins on separate blots using
importin-specific antibodies (Fig. 8D). Endogenous importin 1 and importin 1 were
coimmunoprecipitated (trapped) with both G3-Hinge and G3-A/BD, indicating that these transport factors
specifically interact with NLS-1 and NLS-2 in vivo. In contrast, no consistent interaction above
background levels was observed between importin 7 and G3-Hinge or G3-A/BD (Fig. 8D).
Taken together, we conclude from these results that TR1 nuclear import is facilitated by importin 7,
likely through interactions with NLS-2, and importin 1 and the adapter importin 1 interacting with
NLS-1 and NLS-2, while TR1 nuclear import is facilitated by importin 1/1 interacting with NLS-1.
Further studies with purified recombinant proteins in vitro will be required to confirm this model, since
we were not able to show direct interaction between importin 7 and NLS-2 in this study. When taken out
of the context of the full protein, the A/B domain NLS-2 may not be exposed in a way that promotes
stable binding under the conditions of the GFP-trap assay.
4. Discussion
Our interest for many years has been in the complex mechanisms regulating the subcellular
distribution of TR1. The emerging picture is one of a finely balanced, dynamic process in which TR1
shuttles between the nucleus and cytoplasm. Here, we have further investigated the pathway by which
TR1 enters the nucleus, using in vitro nuclear import assays, importin-specific shRNAs and a small
molecule inhibitor of importin 1, in combination with localization assays in transfected cells and
coimmunoprecipitation assays to confirm interacting partners. The results of this research show that
TR1 can enter the nucleus by more than one pathway; both importin 7 and the classical importin 1/1
heterodimer mediate TR1 nuclear import.
The use of more than one pathway by individual cargos is not without precedent. A striking example is
the human immunodeficiency virus type 1 Rev protein which binds specifically to importin 1,
transportin 1, importin 5, and importin 7 (Arnold et al., 2006). Importin 7 is a notably versatile
karyopherin and often plays a shared role with other karypherin- family members in importing cargo,
ranging from ribosomal proteins (Jakel and Gorlich, 1998) and histones (Baake et al., 2001; Muhlhausser
et al., 2001) to transcription factors, such as c-Jun (Waldmann et al., 2007) and Smad3 (Chuderland et al.,
2008). Adding to its versatility, importin 7 can mediate import either as a monomer or as an importin
7/importin 1 heterodimer (Chook and Suel, 2011).
There is ample evidence that other members of the nuclear receptor superfamily are imported via
multiple pathways. For example, the glucocorticoid receptor (GR) contains two NLSs, NL1 and NL2,
each of which has been shown by in vitro binding assays to interact directly with importin 7 and importin
8, but only NL1 was able to bind the importin / heterodimer. Further, only importin 7 and the importin
/ heterodimer were able to import an NL1-containing fragment of GR in an in vitro import assay
(Freedman and Yamamoto, 2004). In addition, GST pull-down and coimmunoprecipitation assays have
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shown that importin 13 also binds GR, and silencing of importin 13 by RNAi inhibits nuclear import of
GR (Tao et al., 2006). The androgen receptor also contains two NLSs and import is mediated via two
pathways: one that is dependent on importin 1/β1, and one that is importin 1/β1-independent (Cutress
et al., 2008; Kaku et al., 2008).
The six identified mammalian importin  adaptors are ubiquitously expressed, with the exception of
testis-specific importin 6 (Kelley et al., 2010; Kohler et al., 1999). Although interchangeable for many
substrates in vitro, there are reports of preferential use of specific importin  adapters in vivo; for
example, for NF-B (Fagerlund et al., 2005), STAT3 (Liu et al., 2005), the Ran guanine nucleotide
exchange factor, RCC1 (Friedrich et al., 2006; Quensel et al., 2004), and STAT5a (Shin and Reich, 2013).
Our findings suggest that only importin 1 plays a key role in mediating import of TR1, adding to the
preferential use of this adaptor in vivo.
The critical role of nuclear import as a control point for modulating thyroid hormone-responsive gene
expression is apparent, but the physiological significance of multiple import pathways remains to be
determined. Our prior studies have shown that the hinge region of TR1 contains NLS-1, a classical,
bipartite NLS (130KRVAKRKLIEQNRERRRK147; Mavinakere et al., 2012). Data presented here indicate
that import from this classical NLS is mediated by importins 1 and β1 acting together. TR1 also
harbors a second, non-classical NLS, NLS-2, in the N-terminal A/B domain (22PDGKRKRK29;
Mavinakere et al., 2012). TR1 only harbors NLS-1 (Mavinakere et al., 2012) and, as shown here, does
not interact with importin 7. By default, this suggests that the novel monopartite NLS-1 in TR1
provides the signal for use of an alternative pathway for nuclear entry facilitated by importin 7, at a
different time, or in a cooperative fashion with the classical NLS to enable complete, efficient TR1
import. Additional analyses of protein-protein interactions by in vitro binding assays with purified
proteins should help to identify and clarify whether this NLS interacts directly with an importin 7
monomer, or potentially with an importin 7/importin 1 heterodimer , and will allow fuller elucidation of
how multiple pathways serve to regulate nuclear entry in response to cell-specific signals.
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Figure Legends
Fig. 1. In vitro nuclear import of TR1 requires soluble factors and is temperature and energy-dependent.
(A) Digitonin-permeabilized HeLa cells were incubated with import reaction mix containing FITC-GSTTR1 as substrate, under the conditions indicated: 30ºC or 4ºC followed by 30ºC, with an energy
regeneration system or apyrase, and in the presence or absence of rabbit reticulocyte lysate (RRL) as a
source of replacement cytosol. After 30 min, samples were fixed, mounted, and viewed by fluorescence
microscopy. In the presence of RRL, TR1 was localized to the nucleus. In the absence of RRL, and in
chilled or energy-depleted cells, TR1 did not accumulate in the nucleus. Scale bar = 10 m. (B)
Quantification of TR1 nuclear localization. Bars indicate the mean percentage of cells with nuclear
accumulation of TR1 (n=4-5 independent, biologically separate replicate experiments, with 200 cells per
replicate) and error bars indicate  SEM. ***P<0.001; **P<0.01; *P<0.05.
Fig. 2. RNAi specifically knocks down selected importins. (A) HeLa cells were transfected with
importin-specific shRNA plasmids or a scrambled shRNA plasmid as a control, as indicated. RT-qPCR
was used to confirm knockdown of importin mRNA levels. Bars indicate the mean relative expression
level of importin mRNA in cells treated with importin-specific shRNA versus control cells, normalized to
the levels of the housekeeping mRNA GAPDH. Error bars indicate  SEM (n=3 independent,
biologically separate replicates). (B) Immunoblot analysis was used to confirm knockdown of importin
protein levels, as indicated. Bars indicate the mean relative expression level of importin proteins in cells
treated with importin-specific shRNA (knockdown) relative to cells treated with the scrambled shRNA
control, normalized to levels of GAPDH. Error bars indicate  SEM (n=3 independent, biologically
separate replicates). (C) Knockdown is specific for the selected importin. Immunoblot analysis was used
to confirm that knockdown of a target importin with a specific shRNA, as indicated, did not have an
effect on expression levels of other importins.
Fig. 3. Knockdown of importin 1 (Imp 1) and importin 7 (Ipo 7) by RNAi reduces nuclear
accumulation of TR1. (A) HeLa cells cotransfected with shRNA and GFP-TR1 expression plasmids,
as indicated, were analyzed by fluorescence microscopy after staining with DAPI to visualize the nucleus.
Scale bar = 10 m. (B) HeLa cells cotransfected with shRNA and GFP-TR1 expression plasmids were
fixed and scored for TR1 localization: N, completely nuclear; N+C, nuclear and cytoplasmic (with
distinct nucleus); WC, whole cell (nucleus not distinct). Bars indicate the mean percentage of cells in a
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given category (n=3 independent, biologically separate replicate experiments, with 100 cells per
replicate), and error bars indicate  SEM. ***P<0.001; **P<0.01.
Fig. 4. Knockdown of importin 1 (Imp 1) by RNAi reduces nuclear accumulation of TR1. HeLa cells
were transfected with importin-specific shRNA plasmids or a scrambled shRNA plasmid as a control, as
indicated. RT-qPCR (A) and immunoblots (B) were used to confirm knockdown of importin mRNA and
protein levels, respectively. Error bars indicate  SEM (n=3 independent, biologically separate replicates).
(C) HeLa cells cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were
analyzed by fluorescence microscopy. Scale bar = 10 m. (D) HeLa cells cotransfected with shRNA and
GFP-TR1 expression plasmids were scored for TR1 localization: N, completely nuclear; N+C, nuclear
and cytoplasmic (with distinct nucleus); WC, whole cell (nucleus not distinct). Bars indicate the mean
percentage of cells in a given category (n=3 independent, biologically separate replicate experiments,
with 100 cells per replicate), and error bars indicate  SEM. *P<0.05.
Fig. 5. Importazole reduces nuclear localization of TR1 and TR1. HeLa cells were transfected with
GFP-TR1 (A) or GFP-TR1 (B) expression plasmids and untreated, treated with vehicle, or treated for 5
h with 50 M importazole, a small molecule inhibitor of importin 1. Cells were then fixed and scored
for localization of TR1 or TR1: N, completely nuclear; N+C, nuclear and cytoplasmic (with distinct
nucleus); WC, whole cell (nucleus not distinct). Bars indicate the mean percentage of cells in a given
category (n=3 independent, biologically separate replicate experiments, with 200 to 400 cells per
replicate), and error bars indicate  SEM. ***P<0.001.
Fig. 6. Knockdown of importins 4, 5, 8, 9, 11, and 13 has no effect on nuclear accumulation of TR1. (A)
HeLa cells were transfected with importin (Ipo)-specific shRNA plasmids or a scrambled shRNA plasmid
as a control, as indicated, and immunoblot analysis was used to confirm knockdown of importin protein
levels. Error bars indicate  SEM (n=3 independent, biologically separate replicates). (B) HeLa cells
cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were analyzed by
fluorescence microscopy after staining with DAPI to visualize the nucleus. Scale bar = 10 m. (C) HeLa
cells cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were scored for TR1
localization: N, completely nuclear; N+C, nuclear and cytoplasmic (with distinct nucleus); WC, whole
cell (nucleus not distinct). Bars indicate the mean percentage of cells in a given category (n=3
independent, biologically separate replicate experiments, with 100 cells per replicate), and error bars
indicate  SEM. P>0.05.
Fig. 7. Knockdown of importins 4, 1, 7, and 1 does not significantly alter TR1-mediated gene
expression. HeLa cells were cotransfected with expression plasmids for GFP-TRα1, TRE (DR+4)-firefly
luciferase reporter, Renilla luciferase internal control, and scrambled shRNA control or a set of four
target-specific shRNAs, as indicated. Data are presented as fold stimulation in the presence of T3, relative
to luciferase activity (firefly/Renilla) in the absence of T3. Error bars indicate  SEM (n=4 replicates of 8
wells per treatment). P>0.05.
Fig. 8. Importin 1, importin 1, and importin 7 coimmunoprecipitate with TR1. HeLa cells were
transfected with expression plasmids encoding GFP (27 kDa), GFP-TR1 (73 kDa), GST-GFP-NLS (54
kDa), GFP-TR1 (79 kDa), GFP-GST-GFP (G3) (80 kDa), G3-A/BD (containing NLS-2) (86 kDa), or
G3-Hinge (containing NLS-1) (87 kDa), as indicated. Cell lysates were subjected to
coimmunoprecipitation using immobilized anti-GFP-antibodies (GFP-Trap_A). Representative
immunoblots are shown (n=3-5 independent, biologically separate replicate experiments). Protein size
was verified using Pre-Stained Kaleidoscope Protein Standards. (A) Trapped GFP-tagged proteins were
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analyzed by immunoblotting with antibodies specific for GFP. The two lower molecular weight bands in
the GFP-TR1 lane represent specific degradation products. (B) Immunosupernatants (Unbound) and
immunoprecipitates (Bound) from GFP, GFP-TR1, and GST-GFP-NLS-expressing cell lysates were
analyzed on separate immunoblots (using longer exposure times for the immunoprecipitates), with
importin-specific antibodies to detect importin 4 (119 kDa), importin 1 (58 kDa), importin 1 (97 kDa),
and importin 7 (119 kDa), as indicated. The identity of the ~55 kDa band on the importin 1 immunoblot
trapped by GST-GFP-NLS is not known. (C) Immunosupernatants (Unbound) and immunoprecipitates
(Bound) from GFP and GFP- TR1-expressing cell lysates were analyzed by immunoblotting, with
importin-specific antibodies, as indicated. (D) Immunosupernatants (Unbound) and immunoprecipitates
(Bound) from G3-A/BD and GFP-Hinge-expressing cell lysates were analyzed by immunoblotting, with
importin-specific antibodies, as indicated.
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